Armistice Capital Master Fund Ltd. (CIK 0001633584)

Latest company ownership

Shares held
10,596,027
Last filed at
May 19, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
1,342,378
Last filed at
May 10, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Role: 10% Owner
Shares held
816,702
Last filed at
Sep 25, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
Shares held
796,594
Last filed at
Jun 13, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
Shares held
785,000
Last filed at
Aug 3, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
129,298
Last filed at
Jan 23, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4
Shares held
34,370
Last filed at
Jun 28, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q2 2025Q4
Role: Director
Shares held
0
Last filed at
Jun 30, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
Role: 10% Owner
Shares held
0
Last filed at
Oct 5, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 26, 2023 Jun 28, 2023 Avalo Therapeutics, Inc. 10% Owner Sell 17.5 -3,683,542 -82.79% $2.2M
Feb 3, 2023 Feb 9, 2023 Avalo Therapeutics, Inc. 10% Owner Buy 90.0 +450,334 11.26% $1.3K
Mar 10, 2022 Mar 14, 2022 Avalo Therapeutics, Inc. Director Buy 65.0 +226,000 0.47% $151.9K
Mar 3, 2022 Mar 7, 2022 Avalo Therapeutics, Inc. Director Buy 85.0 +510,000 1.08% $344.1K
Feb 24, 2022 Feb 28, 2022 Avalo Therapeutics, Inc. Director Buy 65.0 +140,000 0.30% $111.8K
Feb 17, 2022 Feb 22, 2022 Avalo Therapeutics, Inc. Director Buy 72.5 +288,000 0.62% $231.6K
Jan 18, 2022 Jan 20, 2022 Avalo Therapeutics, Inc. Director Buy 75.0 +312,000 0.67% $274.5K
Jan 12, 2022 Jan 14, 2022 Avalo Therapeutics, Inc. Director Buy 75.0 +455,000 0.99% $452.8K
Jan 7, 2022 Jan 11, 2022 Avalo Therapeutics, Inc. Director Buy 85.0 +645,000 1.42% $642.9K
Sep 15, 2021 Sep 17, 2021 Avalo Therapeutics, Inc. Director Buy 100.0 +5,700,000 14.35% $12.6M
Aug 16, 2021 Aug 18, 2021 Avalo Therapeutics, Inc. Director Buy 60.0 +50,000 0.13% $138.2K
Aug 4, 2021 Aug 6, 2021 Avalo Therapeutics, Inc. 10% Owner Buy 67.5 +150,000 0.38% $408.5K
Jul 30, 2021 Aug 3, 2021 KIORA PHARMACEUTICALS INC 10% Owner Sell 20.0 -260,963 -24.95% $646.6K
Jul 27, 2021 Jul 29, 2021 KIORA PHARMACEUTICALS INC Director Sell 15.0 -3,153,138 -75.09% $14.5M
May 14, 2021 May 18, 2021 Avalo Therapeutics, Inc. Director Buy 62.5 +180,000 0.12% $392.5K
Jan 8, 2021 Jan 12, 2021 Avalo Therapeutics, Inc. Director Buy 93.8 +2,500,000 3.98% $6.5M
Jan 6, 2021 Jan 8, 2021 KIORA PHARMACEUTICALS INC Director Buy 100.0 +1,531,101 29.66% $8M
Dec 11, 2020 Dec 15, 2020 AYTU BIOPHARMA, INC Director Buy 100.0 +1,333,334 100.00% $8M
Dec 3, 2020 Dec 7, 2020 Avalo Therapeutics, Inc. 10% Owner Buy 48.8 +20,000 0.03% $48.8K
Nov 23, 2020 Nov 25, 2020 Avalo Therapeutics, Inc. 10% Owner Buy 60.0 +100,000 0.08% $236.9K
Sep 4, 2020 Sep 9, 2020 TENAX THERAPEUTICS, INC. Director Buy 68.8 +32,000 0.53% $45.5K
Sep 4, 2020 Sep 9, 2020 Avalo Therapeutics, Inc. Director Buy 60.0 +100,000 0.17% $220K
Sep 1, 2020 Sep 3, 2020 TENAX THERAPEUTICS, INC. Director Buy 82.5 +86,000 1.11% $123.2K
Aug 27, 2020 Aug 31, 2020 TENAX THERAPEUTICS, INC. Director Buy 68.8 +32,000 0.57% $47K
Aug 24, 2020 Aug 26, 2020 TENAX THERAPEUTICS, INC. 10% Owner Buy 65.0 +34,903 0.47% $52.7K
Aug 19, 2020 Aug 21, 2020 TENAX THERAPEUTICS, INC. Director Buy 90.0 +311,481 4.67% $460.4K
Jun 26, 2020 Jun 30, 2020 Vaxart, Inc. Director Sell 15.0 -27,612,053 -71.20% $267M
Jun 9, 2020 Jun 11, 2020 Avalo Therapeutics, Inc. 10% Owner Buy 93.8 +2,049,486 3.42% $5.1M
Jun 1, 2020 Jun 3, 2020 Vaxart, Inc. Director Sell 17.5 -1,400,000 -4.52% $3.9M
May 27, 2020 May 29, 2020 Vaxart, Inc. 10% Owner Sell 20.0 -200,000 -1.18% $522K
May 20, 2020 May 22, 2020 Vaxart, Inc. 10% Owner Sell 16.3 -1,750,000 -4.74% $5.4M
May 14, 2020 May 18, 2020 Vaxart, Inc. 10% Owner Sell 16.3 -1,943,308 -4.31% $5.7M
May 11, 2020 May 13, 2020 Vaxart, Inc. 10% Owner Sell 16.3 -3,406,692 -6.17% $10M
May 6, 2020 May 8, 2020 Vaxart, Inc. 10% Owner Sell 37.5 -250,000 -0.39% $632K
May 1, 2020 May 5, 2020 Vaxart, Inc. 10% Owner Sell 16.3 -2,650,000 -3.85% $7.1M
Apr 28, 2020 Apr 30, 2020 Vaxart, Inc. 10% Owner Sell 15.0 -6,600,000 -7.27% $20.1M
Apr 27, 2020 Apr 29, 2020 AYTU BIOPHARMA, INC Director Sell 16.3 -5,108,921 -100.00% $9.3M
Apr 3, 2020 Apr 7, 2020 Avalo Therapeutics, Inc. 10% Owner Buy 47.5 +4,280 0.01% $9.2K
Mar 27, 2020 Mar 31, 2020 Avalo Therapeutics, Inc. 10% Owner Buy 67.5 +111,914 0.38% $265.3K
Mar 20, 2020 Mar 24, 2020 Avalo Therapeutics, Inc. 10% Owner Buy 48.8 +11,000 0.04% $27.5K
Mar 17, 2020 Mar 19, 2020 Avalo Therapeutics, Inc. 10% Owner Buy 92.5 +1,981,219 3.51% $4.1M
Mar 10, 2020 Mar 12, 2020 AYTU BIOPHARMA, INC Director Sell 15.0 -23,514,440 -36.36% $33.1M
Feb 6, 2020 Feb 10, 2020 KIORA PHARMACEUTICALS INC 10% Owner Buy 65.0 +23,000 0.43% $140.5K
Feb 3, 2020 Feb 5, 2020 Avalo Therapeutics, Inc. 10% Owner Buy 88.8 +1,256,282 2.14% $5M
Dec 19, 2019 Dec 23, 2019 AYTU BIOPHARMA, INC 10% Owner Buy 65.0 +78,788 0.33% $67.7K
Nov 5, 2019 Nov 7, 2019 Vaxart, Inc. 10% Owner Buy 60.0 +200,000 0.20% $67.3K
Oct 4, 2019 Oct 7, 2019 Vaxart, Inc. 10% Owner Buy 72.5 +564,000 0.76% $203.2K
Oct 1, 2019 Oct 3, 2019 Vaxart, Inc. 10% Owner Buy 65.0 +436,000 0.45% $150.6K
Sep 29, 2019 Oct 1, 2019 KIORA PHARMACEUTICALS INC 10% Owner Buy 95.0 +605,001 9.22% $1.9M
Sep 26, 2019 Sep 30, 2019 Vaxart, Inc. 10% Owner Buy 95.0 +7,333,333 8.68% $2.1M
Sep 23, 2019 Sep 25, 2019 Traws Pharma, Inc. 10% Owner Sell 36.3 -10,249 -0.62% $13K
Sep 4, 2019 Sep 6, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 96.3 +2,200,000 5.62% $6.7M
Aug 29, 2019 Sep 3, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 60.0 +41,764 0.07% $134.6K
Aug 16, 2019 Aug 20, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 48.8 +12,184 0.02% $42.2K
Aug 12, 2019 Aug 14, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 97.5 +100,000 15.55% $332.6K
Jun 11, 2019 Jun 13, 2019 ACHIEVE LIFE SCIENCES, INC. 10% Owner Sell 22.5 -47,182 -1.90% $134.8K
Jun 11, 2019 Jun 13, 2019 ACHIEVE LIFE SCIENCES, INC. 10% Owner Sell 20.0 -252,150 -1.59% $788.8K
Jun 7, 2019 Jun 11, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 56.3 +10,000 0.05% $48.8K
Jun 3, 2019 Jun 5, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +15,000 0.03% $72.2K
May 29, 2019 May 31, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 60.0 +51,000 0.07% $240.2K
May 23, 2019 May 28, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +29,000 0.04% $145.5K
May 16, 2019 May 20, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +10,000 0.02% $51.8K
May 10, 2019 May 14, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +20,000 0.03% $99.3K
Mar 27, 2019 Mar 29, 2019 KIORA PHARMACEUTICALS INC 10% Owner Buy 72.5 +549,647 0.79% $175.2K
Mar 25, 2019 Mar 27, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 62.5 +50,000 0.07% $273.3K
Mar 6, 2019 Mar 8, 2019 Avalo Therapeutics, Inc. 10% Owner Buy 65.0 +374,486 0.16% $2.1M
Jan 18, 2019 Jan 23, 2019 BIO-PATH HOLDINGS, INC. 10% Owner Sell 22.5 -64,457 -19.95% $171.6K
Dec 28, 2018 Dec 31, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +38,799 0.04% $121.8K
Dec 14, 2018 Dec 18, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +50,000 0.04% $165.4K
Dec 10, 2018 Dec 12, 2018 KIORA PHARMACEUTICALS INC 10% Owner Buy 56.3 +100,353 0.06% $40.3K
Dec 6, 2018 Dec 10, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +36,400 0.01% $124.1K
Nov 30, 2018 Dec 4, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +25,797 0.02% $90.2K
Nov 27, 2018 Nov 29, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 62.5 +77,803 0.06% $272.9K
Nov 21, 2018 Nov 26, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +50,000 0.04% $179.4K
Nov 16, 2018 Nov 20, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +49,100 0.03% $177.3K
Nov 14, 2018 Nov 16, 2018 KIORA PHARMACEUTICALS INC 10% Owner Buy 65.0 +360,000 0.24% $161.4K
Nov 13, 2018 Nov 15, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +31,314 0.02% $120.6K
Oct 30, 2018 Nov 1, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 48.8 +5,986 0.01% $23.5K
Oct 25, 2018 Oct 29, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 62.5 +107,800 0.07% $425.5K
Oct 22, 2018 Oct 25, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 55.0 +125,800 0.04% $519.1K
Oct 4, 2018 Oct 9, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +29,600 0.02% $128.4K
Oct 3, 2018 Oct 5, 2018 CASSAVA SCIENCES INC 10% Owner Sell 20.0 -512,660 -23.69% $671.7K
Sep 25, 2018 Sep 27, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +20,400 0.01% $94.6K
Aug 16, 2018 Aug 20, 2018 CASSAVA SCIENCES INC 10% Owner Sell 17.5 -1,256,000 -7.60% $1.3M
Aug 17, 2018 Aug 20, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 92.5 +1,000,000 2.94% $3.9M
Jul 30, 2018 Aug 1, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 48.8 +2,855 0.00% $12.1K
Jul 25, 2018 Jul 27, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +28,926 0.02% $127.6K
Jul 16, 2018 Jul 18, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +30,019 0.02% $128.4K
Jun 28, 2018 Jul 2, 2018 Avalo Therapeutics, Inc. Director Buy 52.5 +18,200 0.02% $74.8K
May 25, 2018 May 30, 2018 KIORA PHARMACEUTICALS INC 10% Owner Buy 48.8 +58,275 0.05% $33.4K
May 21, 2018 May 23, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +50,000 0.04% $189.2K
May 18, 2018 May 22, 2018 KIORA PHARMACEUTICALS INC Director Buy 47.5 +1,725 0.01% $959.1
May 15, 2018 May 17, 2018 Avalo Therapeutics, Inc. Director Buy 62.5 +130,000 0.11% $467.6K
May 14, 2018 May 16, 2018 KIORA PHARMACEUTICALS INC Director Buy 47.5 +15,758 0.02% $8.4K
May 9, 2018 May 11, 2018 KIORA PHARMACEUTICALS INC 10% Owner Buy 60.0 +177,012 0.15% $91K
May 4, 2018 May 8, 2018 KIORA PHARMACEUTICALS INC 10% Owner Buy 60.0 +137,230 0.06% $63.5K
Apr 25, 2018 Apr 27, 2018 KIORA PHARMACEUTICALS INC 10% Owner Buy 65.0 +165,522 0.20% $89.3K
Apr 19, 2018 Apr 23, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 52.5 +20,000 0.02% $75.1K
Apr 18, 2018 Apr 20, 2018 KIORA PHARMACEUTICALS INC 10% Owner Buy 87.5 +2,534,478 2.38% $1.2M
Apr 16, 2018 Apr 18, 2018 Avalo Therapeutics, Inc. 10% Owner Buy 62.5 +150,000 0.13% $512.4K